Cargando…

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy

Over thirty years of extensive research has not yet solved the complexity of HIV pathogenesis leading to a continued need for a successful cure. Recent immunotherapy-based approaches are aimed at controlling the infection by reverting immune dysfunction. Comparatively less appreciated than the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehraj, Vikram, Jenabian, Mohammad-Ali, Vyboh, Kishanda, Routy, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302459/ https://www.ncbi.nlm.nih.gov/pubmed/25624956 http://dx.doi.org/10.2174/1874613601408010066

Ejemplares similares

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients
por: Lu, Wei, et al.
Publicado: (2015)

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2016)

IDO-induced immunosuppressive tryptophan catabolism following primary HIV infection
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator?
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2012)

The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
por: Routy, Jean-Pierre, et al.
Publicado: (2016)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation
por: Allam, Ossama, et al.
Publicado: (2018)

Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
por: Routy, Jean-Pierre, et al.
Publicado: (2017)

The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
por: Mehraj, Vikram, et al.
Publicado: (2016)

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
por: Mehraj, Vikram, et al.
Publicado: (2016)

Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
por: Mehraj, Vikram, et al.
Publicado: (2015)

Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia
por: Younas, Mehwish, et al.
Publicado: (2017)

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era
por: Cao, Wei, et al.
Publicado: (2016)

Use of (1→3)‐β‐d‐glucan for diagnosis and management of invasive mycoses in HIV‐infected patients
por: Farhour, Zahra, et al.
Publicado: (2018)

Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation
por: Ramendra, Rayoun, et al.
Publicado: (2019)

Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
por: Ponte, Rosalie, et al.
Publicado: (2016)

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection
por: Valiente-Echeverría, Fernando, et al.
Publicado: (2014)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial
por: Lebouché, Bertrand, et al.
Publicado: (2014)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2021)

HIV persistence in mucosal CD4(+) T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
por: Alexandrova, Yulia, et al.
Publicado: (2022)

Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters
por: Guo, Fu-Ping, et al.
Publicado: (2016)

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
por: Mehraj, Vikram, et al.
Publicado: (2019)

HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA
por: Ajamian, Lara, et al.
Publicado: (2015)

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
por: Wacleche, Vanessa Sue, et al.
Publicado: (2016)

Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression
por: Hubert, Audrey, et al.
Publicado: (2015)

The Use of CBD and Its Synthetic Analog HU308 in HIV-1-Infected Myeloid Cells
por: Williams, Anastasia, et al.
Publicado: (2023)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
por: Mehraj, Vikram, et al.
Publicado: (2017)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

Regulatory T Cells Negatively Affect IL-2 Production of Effector T Cells through CD39/Adenosine Pathway in HIV Infection
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jl24s70aj6kq8k46q455cl4s30